Solventum Corp (SOLV)

Solventum Corp is a healthcare company listed on the NYSE under the ticker SOLV. The company develops, manufactures, and commercializes a range of solutions designed to address customer and patient needs in the United States and international markets. Its operations are organized into three segments: Medsurg, Dental Solutions, and Health Information Systems.

The Medsurg segment includes products and technologies used in wound care, skin care, sterilization assurance, temperature management, surgical supplies, medical tapes, stethoscopes, and related applications. Dental Solutions covers products for preventive care, restorative treatments, and orthodontic use, including brackets, aligners, cements, and bonding agents. Health Information Systems provides software and workflow tools such as physician documentation, coding automation, speech recognition, classification methods, and data visualization platforms. Solventum was incorporated in 2023 and is headquartered in Eagan, Minnesota.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NYSE-SOLV
$87.57
-1.1% Downside
Fair
$93.92
6.1% Upside
Fair
Good
0.0%
November 5, 2026
10.5x
3.1x
1.8x
15.121 B
19.979 B
25.9%
84.6%
3.1
-8.2%
Valuation • Fair Value

Solventum Corp (NYSE-SOLV) Fair Value by Valuation Model

Review the available estimates for Solventum Corp (NYSE-SOLV), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$87.57

Estimated downside of 1.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$96.27

Discounted cash flow valuation reference.

Ben Graham Formula Value

$93.47

Classic Ben Graham valuation formula reference.

EPV Fair Value

$88.81

Earnings power value estimate.

Comps Fair Value

$78.67

Comparable-company valuation reference.

Analyst Price Target

$93.92

Analysts imply upside of 6.1%.

How to read these valuation models

Use the 7 available valuation references for Solventum Corp (NYSE-SOLV) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Solventum Corp (NYSE-SOLV)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

8.31 B

Current operating scale indicator.

Revenue Forecast

8.237 B

Forward revenue estimate.

EBITDA

1.139 B

Current operating profitability reference.

EBITDA Forecast

2.032 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Solventum Corp (NYSE-SOLV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Solventum Corp (NYSE-SOLV)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-1.94

Intermediate zone that deserves monitoring.

Altman Z-Score

3.1

Relatively strong balance-sheet zone.

FCF / Net Income

-8.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Solventum Corp (NYSE-SOLV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Solventum Corp (NYSE-SOLV)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 5, 2026

Days to Earnings

49

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Solventum Corp (NYSE-SOLV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Solventum Corp (NYSE-SOLV) Stock Forecast & Technical Outlook

Review Solventum Corp (NYSE-SOLV) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Solventum Corp (NYSE-SOLV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Solventum Corp (NYSE-SOLV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Solventum Corp (NYSE-SOLV) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Solventum Corp (NYSE-SOLV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Solventum Corp (NYSE-SOLV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Solventum Corp (NYSE-SOLV)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Solventum Corp (NYSE-SOLV) has a Buy consensus, with 7 buy, 5 hold and 1 sell recommendations in the current data set.

Buy 7
Hold 5
Sell 1
FAQ Fast Investor Answers

Solventum Corp (NYSE-SOLV) Stock FAQ

Data-supported answers about Solventum Corp (NYSE-SOLV), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$87.57
Estimated downside 1.1%
Valuation Rating
Near Fair Value
Price is close to fair value
Analyst Target
$93.92
Implied upside 6.1%
Financial Health
Good
Current financial-health read

The current fair value estimate for Solventum Corp (NYSE-SOLV) is $87.57. This implies an estimated downside of 1.1% versus the current market price.

Based on the current fair value estimate, the stock is trading close to its estimated fair value.

The available analyst price target for Solventum Corp (NYSE-SOLV) is $93.92. The analyst target implies estimated upside of 6.1%.

The current financial health read for Solventum Corp (NYSE-SOLV) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Solventum Corp (NYSE-SOLV) is November 5, 2026.

The latest available data indicates no current dividend yield for Solventum Corp (NYSE-SOLV).

The current P/E ratio listed for Solventum Corp (NYSE-SOLV) is 10.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Solventum Corp is 15.121 B.

The current enterprise value listed for Solventum Corp is 19.979 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Solventum Corp is NYSE-SOLV, and the stock is listed on NYSE.

Solventum Corp (NYSE-SOLV) is listed on NYSE.

The current debt-to-total-capital ratio listed for Solventum Corp is 25.9%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Solventum Corp is 84.6%. Free float helps investors understand how much of the share base is available for public trading.